| The role of evolution in the emergence of infectious diseases R Antia, RR Regoes, JC Koella, CT Bergstrom Nature 426 (6967), 658-661, 2003 | 589 | 2003 |
| High-avidity IgA protects the intestine by enchaining growing bacteria K Moor, M Diard, ME Sellin, B Felmy, SY Wotzka, A Toska, E Bakkeren, ... Nature 544 (7651), 498-502, 2017 | 385 | 2017 |
| Pharmacodynamic functions: a multiparameter approach to the design of antibiotic treatment regimens RR Regoes, C Wiuff, RM Zappala, KN Garner, F Baquero, BR Levin Antimicrobial agents and chemotherapy 48 (10), 3670-3676, 2004 | 357 | 2004 |
| Dynamic variation in cycling of hematopoietic stem cells in steady state and inflammation H Takizawa, RR Regoes, CS Boddupalli, S Bonhoeffer, MG Manz Journal of Experimental Medicine 208 (2), 273-284, 2011 | 354 | 2011 |
| Stabilization of cooperative virulence by the expression of an avirulent phenotype M Diard, V Garcia, L Maier, MNP Remus-Emsermann, RR Regoes, ... Nature 494 (7437), 353-356, 2013 | 322 | 2013 |
| Population biological principles of drug-resistance evolution in infectious diseases PA Zur Wiesch, R Kouyos, J Engelstädter, RR Regoes, S Bonhoeffer The Lancet infectious diseases 11 (3), 236-247, 2011 | 299 | 2011 |
| Phenotypic tolerance: antibiotic enrichment of noninherited resistance in bacterial populations C Wiuff, RM Zappala, RR Regoes, KN Garner, F Baquero, BR Levin Antimicrobial agents and chemotherapy 49 (4), 1483-1494, 2005 | 272 | 2005 |
| The HIV coreceptor switch: a population dynamical perspective RR Regoes, S Bonhoeffer Trends in microbiology 13 (6), 269-277, 2005 | 255 | 2005 |
| Combination effects of antimicrobial peptides G Yu, DY Baeder, RR Regoes, J Rolff Antimicrobial agents and chemotherapy 60 (3), 1717-1724, 2016 | 237 | 2016 |
| Emergence of drug-resistant influenza virus: population dynamical considerations RR Regoes, S Bonhoeffer science 312 (5772), 389-391, 2006 | 212 | 2006 |
| Salmonella persisters promote the spread of antibiotic resistance plasmids in the gut E Bakkeren, JS Huisman, SA Fattinger, A Hausmann, M Furter, A Egli, ... Nature 573 (7773), 276-280, 2019 | 207 | 2019 |
| Evolution of virulence in a heterogeneous host population RR Regoes, MA Nowak, S Bonhoeffer Evolution 54 (1), 64-71, 2000 | 203 | 2000 |
| Insect antimicrobial peptides show potentiating functional interactions against Gram-negative bacteria M Rahnamaeian, M Cytryńska, A Zdybicka-Barabas, K Dobslaff, ... Proceedings of the Royal Society B: Biological Sciences 282 (1806), 20150293, 2015 | 189 | 2015 |
| Predicting drug resistance evolution: insights from antimicrobial peptides and antibiotics G Yu, DY Baeder, RR Regoes, J Rolff Proceedings of the Royal Society B: Biological Sciences 285 (1874), 20172687, 2018 | 184 | 2018 |
| Determinants of HIV-1 broadly neutralizing antibody induction P Rusert, RD Kouyos, C Kadelka, H Ebner, M Schanz, M Huber, DL Braun, ... Nature medicine 22 (11), 1260-1267, 2016 | 178 | 2016 |
| Dose–dependent infection rates of parasites produce the Allee effect in epidemiology RR Regoes, D Ebert, S Bonhoeffer Proceedings of the Royal Society of London. Series B: Biological Sciences …, 2002 | 171 | 2002 |
| Cecum lymph node dendritic cells harbor slow-growing bacteria phenotypically tolerant to antibiotic treatment P Kaiser, RR Regoes, T Dolowschiak, SY Wotzka, J Lengefeld, E Slack, ... PLoS biology 12 (2), e1001793, 2014 | 148 | 2014 |
| The role of compensatory mutations in the emergence of drug resistance A Handel, RR Regoes, R Antia PLoS computational biology 2 (10), e137, 2006 | 144 | 2006 |
| MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1 CR Ruprecht, A Krarup, L Reynell, AM Mann, OF Brandenberg, ... Journal of Experimental Medicine 208 (3), 439-454, 2011 | 128 | 2011 |
| Virus dynamics: the effect of target cell limitation and immune responses on virus evolution RR Regoes, D Wodarz, MA Nowak Journal of theoretical biology 191 (4), 451-462, 1998 | 127 | 1998 |
Sebastian BonhoefferTheoretical Biology, ETH Zurich確認したメール アドレス: env.ethz.ch
